Fidelity Investments’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-674,800
| Closed | -$6.87M | – | 4463 |
|
|
2020
Q3 | $6.87M | Sell |
674,800
-67,200
| -9% | -$684K | ﹤0.01% | 1960 |
|
|
2020
Q2 | $11.1M | Sell |
742,000
-46,600
| -6% | -$694K | ﹤0.01% | 1782 |
|
|
2020
Q1 | $9.61M | Sell |
788,600
-83,400
| -10% | -$1.02M | ﹤0.01% | 1703 |
|
|
2019
Q4 | $13.8M | Hold |
872,000
| – | – | ﹤0.01% | 1733 |
|
|
2019
Q3 | $10.7M | Buy |
872,000
+55,000
| +7% | +$675K | ﹤0.01% | 1800 |
|
|
2019
Q2 | $10.8M | Buy |
+817,000
| New | +$10.8M | ﹤0.01% | 1853 |
|